Neither Body nor Brain: Comparing Preventive Attitudes to Prostate Cancer and Alzheimer’s Disease

Abstract

This article compares health promotion attitudes towards prostate cancer and Alzheimer’s disease. Our aim is to demonstrate that these two apparently distinct conditions of the aging body – one affecting the male reproductive system, the other primarily the brain – are addressed in similar fashion in recent public health activities because of a growing emphasis on a ‘cardiovascular logic’. We suggest that this is a form of reductionism, and argue that it leaves us with a dangerous paradox: while re-transcending, at least partially, the conceptual separation of body and brain, it clouds much-needed discussion and research, such as contingent issues of socio-economic and socio-cultural disease disparities.

Keywords

Alzheimer’s disease body/brain cardiovascular logic prevention prostate cancer

Get full access to this article

View all access options for this article.

References

AllBusiness (2007) Early detection push. Available at: http://www.allbusiness.com/insurance/health-insurance-government-health-medicare/6622991-1.html (accessed April 2011).

Alzheimer’s Association (2010) Know the 10 signs. Available at: http://www.alz.org/alzheimers_disease_know_the_10_signs.asp (accessed December 2010).

American Cancer Society (2011) Prostate cancer: What’s new in prostate cancer research and treatment. Available at: http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-new-research (accessed January 2012).

American Heart Association (2010) Cardiovascular disease and diabetes. Available at: http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp (accessed October 2010).

Armstrong

(1995) The rise of surveillance medicine. Sociology of Health & Illness 17(3): 393–404.

Armstrong

(2009) Origins of the problem of health-related behaviours: A genealogical study. Social Studies of Science 39(6): 909–926.

Armstrong

(2010) Is the focus on health-related behaviours a new phenomenon? An answer to Vallgarda (2010). Social Studies of Science 40(4): 615–617.

Aronowitz

(2007) Unnatural History: Breast Cancer and American Society. New York: Cambridge University Press.

Aronowitz

(2009) The converged experience of risk and disease. Milbank Quarterly 87: 417–442.

10.

Battistin

Cagnin

(2010) Vascular cognitive disorder: A biological and clinical overview. Neurochemical Research 35(12): 1933–1938.

11.

Bekkering

. (2006) A systematic review of RCTs investigating the effect of dietal and physical activity interventions on cancer survival. Available at: http://www.dietandcancerreport.org/ (accessed January 2012).

12.

Bell

(2010) Cancer survivorship, mor(t)ality and lifestyle discourses on cancer prevention. Sociology of Health & Illness 32(3): 349–364.

13.

Bell

Kazanjian

(2011) PSA testing: molecular technologies and men’s experience of prostate cancer survivorship. Health, Risk & Society 13(2): 183–196.

14.

Bell

McNaughton

Salmon

(eds) (2011) Alcohol, Tobacco and Obesity: Morality, Mortality and the New Public Health. London: Routledge.

15.

Berufsverbands österreichischer Urologen CliniCum Urologie (2007) Krebsvorsorge beim Mann. Available at: http://www.clinicum.at/dynasite.cfm?dsmid=8295&dspaid=654143 (accessed March 2011).

16.

Bettuzzi

. (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia. Cancer Research 66: 1234–1240.

17.

Bird

(2007) Perceptions of epigenetics. Nature 447: 396–398.

18.

Blumenthal

. (2007) Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosomatic Medicine 69(7): 587–596.

19.

Burchell

(1996) Liberal government and techniques of the self. In: Barry

Osborne

Rose

(eds) Foucault and Political Reason. London: UCL Press.

20.

Campbell

(2004) The human face of Alzheimer’s. The New Atlantis 6: 3–17.

21.

Canadian Mental Health Association (2010) 10 tips for mental health. Available at: http://www.cmha.ca/bins/content_page.asp?cid=4-42-214 (accessed October 2010).

22.

Cantor

(2007) Introduction: Cancer control and prevention in the twentieth century. Bulletin of the History of Medicine 81: 1–38.

23.

Carey

(2010) Genes as mirrors of life experiences. New York Times 8 November. Available at: http://www.nytimes.com/2010/11/09/health/09brain.html (accessed November 2010).

24.

Castel

(1991) From dangerousness to risk. In: Burchell

Colin

Miller

(eds) The Foucault Effect: Studies in Governmentality. Chicago, IL: University of Chicago Press, 281–298.

25.

Chan

. (2005) Role of diet in prostate cancer development and progression. Journal of Clinical Oncology 23: 8152–8160.

26.

Cheng

. (2004) Prostatic intraepithelial neoplasia: An update. Clinical Prostate Cancer 3: 26–30.

27.

Cheng

. (2009) Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes & Control 20(8): 1431–1440.

28.

Crawford

(2006) Healthism and the medicalization of everyday life. Health 10(4): 401–420.

29.

Cyranoski

(2011) Alzheimer’s disease genes aid the search for preventive drugs. Nature 22 July. Available at: http://www.nature.com/news/2011/110722/full/news.2011.433.html (accessed December 2011).

30.

Czene

. (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family cancer database. International Journal of Cancer 99(2): 260–266.

31.

Dang

(2010) Walking away the blues: Exercise for depression in older adults. Nursing 40(11): 33–36.

32.

Daston

(2000) The coming into being of scientific objects. In: Daston

(ed.) Biographies of Scientific Objects. Chicago, IL: University of Chicago Press, 1–14.

33.

Davison

Goldenberg

(2011) Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. British Journal of Urology 185(2): 477–482.

34.

De Nunzio

. (2011) Association of obesity with prostate cancer: A case-control study. British Journal of Cancer 104(5): 875–881.

35.

DiaGenic (2010) DiaGenic and Pfizer to collaborate on blood based biomarkers for early stages of Alzheimer’s disease. Available at: http://www.cisionwire.com/diagenic-asa/r/diagenic-and-pfizer-to-collaborate-on-blood-based-biomarkers-for-early-stages-of-alzheimer-s-disease,c533559 (accessed April 2011).

36.

Dimitropoulou

. (2011) Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study. British Journal of Cancer 104(5): 875–881.

37.

Dubois

. (2007) Research criteria for the diagnosis of Alzheimer’s disease. Lancet Neurology 6(8): 734–746.

38.

Dubois

. (2010) Revising the definition of Alzheimer’s disease: A new lexicon. Lancet Neurology 9(11): 1118–1127.

39.

Dumit

(2010) Pharmaceutical witnessing: Drugs for life in an era of direct-to-consumer advertising. In: Edwards

. (eds) Technologized Images, Technologized Bodies. Oxford: Berghahn.

40.

Ecks

(2009) Welcome home, Descartes! Rethinking the anthropology of the body. Perspectives in Biology and Medicine 52(1): 153–158.

41.

Engel

(1977) The need for a new medical model: A challenge for biomedicine. Science 196: 129–136.

42.

Engs

(1991) Resurgence of a new ‘clean living’ movement in the United States. Journal of School Health 61(4): 155–189.

43.

Ferenczi

. (2010) Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? American Journal of Cardiology 106(4): 587–592.

44.

Fletcher

(2010) Will the entire population be overweight by 2230? Common sense, scientific consensus and the ‘obesity epidemic’. In: Mathar

Jansen

YJFM

(eds) Health Promotion and Prevention Programmes in Practice. Bielefeld: Transcript, 53–82.

45.

Focus (2010) Die Herz-Diät. Title page, March.

46.

Foucault

(1991) Governmentality. In: Gordon

Miller

(eds) The Foucault Effect: Studies in Governmentality. Chicago, IL: University of Chicago Press, 87–104.

47.

Friedland

(2001) Should dietary modifications be recommended to lower the risk of Alzheimer's disease? Paper presented at 53rd Annual Meeting, American Academy of Neurology, Philadelphia, 6 May.

48.

Friedman

Rosenman

(1959) Association of specific overt behavior patterns with blood and cardiovascular findings. Journal of the American Medical Association 169: 1286–1296.

49.

Gauthier

. (2011) Commentary on ‘Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease’. A Canadian perspective. Alzheimer’s & Dementia 7: 330–332.

50.

George

Whitehouse

(2009) The classifications of Alzheimer's disease and mild cognitive impairment: Enriching therapeutical models. In: Ballenger

. (eds) Do We Have a Pill for That? Treating Dementia. Baltimore, MD: Johns Hopkins University Press, 5–24.

51.

Gilligan

(2005) Social disparities and prostate cancer: Mapping the gaps in our knowledge. Cancer Causes & Control 16(1): 45–53.

52.

Giovannucci

. (2005) A prospective study of physical activity and incident and fatal prostate cancer. Archives of Internal Medicine 165(9): 1005–1010.

53.

Greco

(2006) Psychosomatic subjects and the ‘duty to be well’. Economy and Society 22(3): 357–372.

54.

Greene

(2007) Prescribing by Numbers: Drugs and the Definition of Disease. Baltimore, MD: Johns Hopkins University Press.

55.

Hagner

(2008) Homo cerebralis. Der Wandel vom Seelenorgan zum Gehirn. Frankfurt: Suhrkamp.

56.

Harris

(2011) US panel says no to prostate screening for healthy men. New York Times 6 October. Available at: http://www.nytimes.com/2011/10/07/health/07prostate.html (accessed December 2011).

57.

Health Canada (2010) What is healthy living? Available at: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/index-eng.php (accessed November 2010).

58.

Heimann

(2009) Einmal durch Gehirn und Prostata. Available at: http://www.medica.de/cipp/md_medica/custom/pub/content,oid,29919/lang,1/ticket,g_u_e_s_t/∼/Einmal_durch_Gehirn_und_Prostata.html (accessed March 2010).

59.

Holly

(2005) Age-defying exercise. Alive. Available at: http://www.alive.com/583a2a2.php?subject_bread_cramb=111 (accessed October 2010).

60.

Hori

. (2011) Prostate cancer and diet: Food for thought. BJU International 107(9): 1348–1359.

61.

Johnsen

. (2009) Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. International Journal of Cancer 125(4): 902–908.

62.

Johnson & Johnson (2010) Available at: http://www.jnj.com/releasedetail.cfm?releaseid=534058 (accessed April 2011).

63.

Kalaria

(2010) Vascular basis for brain degeneration: Faltering controls and risk factors for dementia. Nutrition Reviews 68 (suppl. 2): S74–S87.

64.

Kampf

(2009) The absence of Adam: Prostate cancer and male identity. In: Powell

Gilbert

(eds) Aging and Identity: A Postmodern Dialogue. New York: Nova Science Publishers.

65.

Kampf

(2010) Risk of age? Early detection test, prostate cancer and practices of self. Journal of Aging Studies 24(4): 325–334.

66.

Kampf

Botelho

(2009) Anti-aging and biomedicine: Bodies, gender, and the pursuit of longevity. Medicine Studies: An International Journal for History, Philosophy, and Ethics of Medicine & Allied Sciences 1(3): 187–195.

67.

Kaplan

(2007) Metabolic dysfunction and male pelvic health. European Urology 52(2): 316–317.

68.

Khachaturian

(2011) Revised criteria for diagnosis of Alzheimer’s disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia 7(3): 253–256.

69.

Kral

(1962) Senescent forgetfulness: Benign and malignant. Canadian Medical Association Journal 86: 257–260.

70.

La Berge

(2008) How the ideology of low fat conquered America. Journal of the History of Medicine and Allied Sciences 6(2): 139–177.

71.

Latour

(2000) On the partial existence of existing and nonexisting objects. In: Daston

(ed.) Biographies of Scientific Objects. Chicago, IL: University of Chicago Press, 247–269.

72.

Leibing

(2006) Divided gazes: Alzheimer’s disease, the person within, and death in life. In: Leibing

Cohen

(eds) Thinking about Dementia – Culture, Loss, and the Anthropology of Senility. Piscataway, NJ: Rutgers University Press, 240–268.

73.

Leibing

(2009a) Tense prescriptions? Alzheimer medications and the anthropology of uncertainty. Transcultural Psychiatry 46(1): 180–206.

74.

Leibing

(2009b) From the periphery to the center: Treating behavioural and psychological symptoms in dementia. In: Ballenger

. (eds) Do We Have a Pill for That? Treating Dementia. Batimore, MD: Johns Hopkins University Press, 74–97.

75.

Leichter

(1998) Lifestyle correctness and the new secular morality. In: Brandt

Rozin

(eds) Morality and Health. New York: Routledge, 359–378.

76.

Levine

(2010) Defying Dementia: Understanding and Preventing Alzheimer’s and Related Disorders. Lanham, MD: Rowman and Littlefield.

77.

Levy

Brink

(2005) A Change of Heart: How the Framingham Heart Study Helped Unravel the Mysteries of Cardiovascular Disease. New York: Alfred A. Knopf.

78.

Lippman

. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial. Journal of the American Medical Association 301(1): 39–51.

79.

Lopez

(2008) Is obesity contagious? Expert Review of Endocrinology and Metabolism 3(1): 21–22.

80.

Löwy

(2007) Breast cancer and the ‘materiality of risk’: The rise of morphological prediction. Bulletin of the History of Medicine 81(1): 241–266.

81.

Löwy

(2010) Preventive Strikes: Women, Precancer, and Prophylactic Surgery. Baltimore, MD: Johns Hopkins University Press.

82.

Löwy

(2011) Labelled bodies: Classification of diseases and the medical way of knowing. History of Science 49(3): 299–315.

83.

Mayo Clinic (2011) Prostate cancer: Prevention. Available at: http://www.mayoclinic.com/health/prostate-cancer-prevention/MC00027 (accessed January 2012).

84.

McIlroy

(2010) New tools allow for early detection of Alzheimer’s. Globe and Mail 22 September. Available at: http://www.theglobeandmail.com/life/health/dementia/new-tools-allow-for-early-detection-of-alzheimers-but-theres-a-catch/article1717718/ (accessed September 2010).

85.

Mead

. (2008) Exercise for depression. Cochrane Database System Review 8(4): CD004366.

86.

Moore

. (2009) Age-specific physical activity and prostate cancer risk among white men and black men. Cancer 115(21): 5060–5070.

87.

Moore

SEH

(2010) Is the healthy body gendered? Toward a feminist critique of the new paradigm of health. Body & Society 16(2): 95–118.

88.

Morgan

. (2011) Glutamatergic neurons in rodent models respond to nanoscale particulate urban air pollutants in vivo and in vitro . Environmental Health Perspectives 119(7): 1003–1009.

89.

Mroz

. (2011) Gender influences on men’s diets. American Journal of Men’s Health 5(2): 177–187.

90.

Mullner

(2007) A change of heart: How the Framingham Heart Study helped unravel the mysteries of cardiovascular disease (review). Journal of the History of Medicine and Allied Sciences 62(1): 113–115.

91.

Narayan

KMV

(2010) A case of well-intentioned public health reductionism? BMJ Groups Blog. Available at: http://blogs.bmj.com/bmj/2010/03/04/k-m-venkat-narayan-a-case-of-well-intentioned-public-health-reductionism/ (accessed June 2012).

92.

National Cancer Institute (2012) Cancer health disparities. Available at: http://cancer.gov/cancertopics/factsheet/disparities/cancerhealthdisparities (accessed May 2012).

93.

Nixon

Gomez

(2007) The Prostate Health Program: A Guide to Preventing and Controlling Prostate Cancer. New York: Simon and Schuster.

94.

Northwestern University (2010) Healthy lifestyle has bigger impact on cardiovascular health than genetics. ScienceDaily 15 November. Available at: http://www.sciencedaily.com/releases/2010/11/101115151954.htm (accessed 16 November 2010).

95.

Oppenheimer

(2005) Becoming the Framingham Study, 1947–1950. American Journal of Public Health 95: 602–610.

96.

Ozten-Kandaş

Bosland

(2011) Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants. Journal of Carcinogenesis 10: 27.

97.

Pap

. (2009) Immediate and delayed effects of cognitive interventions in healthy elderly. Alzheimer's & Dementia 5: 50–60.

98.

Pedersen

(2010) Reaching the limits of genome-wide significance in Alzheimer disease. Journal of the American Medical Association 303: 1864–1865.

99.

Petersen

(2006) The genetic conception of health: Is it as radical as claimed? Health 10(4): 481–500.

100.

Petersen

Lupton

(1996) The New Public Health: Health and Self in the Age of Risk. London: Sage.

101.

Petersen

. (2010) Healthy living and citizenship: An overview. Critical Public Health 20(4): 1–10.

102.

Petersen

(2004) Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 52(3): 183–194.

103.

Pfizer (2010) Major partnership establishes professorship in prevention of dementia and Alzheimer’s. Available at: http://www.pfizer.ca/en/media_centre/news_releases/article?year=2010&article=339 (accessed April 2011).

104.

Pitts-Taylor

(2010) The plastic brain: Neoliberalism and the neuronal self. Health 14(6): 635–652.

105.

Rabin

(2010) ‘Good’ cholesterol may lower Alzheimer’s risk. New York Times 16 December. Available at: http://well.blogs.nytimes.com/2010/12/16/good-cholesterol-may-lower-alzheimers-risk/?emc=eta1 (accessed December 2010).

106.

Ramis

. (2011) Prostate cancer and industrial pollution risk around putative focus in a multi-source scenario. Environment International 37(3): 577–585.

107.

Rapoport

Mulsant

(2010) Pathway to prevention: Great progress has been made but we are not yet there. International Psychogeriatrics 22: 1193–1195.

108.

Reeves

(2011) Planète Cœur: Santé cardiaque et environnement. Montréal: MultiMondes.

109.

Reisberg

(1981) A Guide to Alzheimer’s Disease for Families, Spouses, and Friends. New York: The Free Press.

110.

Richman

. (2011) Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: Incidence and survival. Cancer Prevention Research 4(12): 2110–2121.

111.

Riska

(2000) The rise and fall of Type A man. Social Science & Medicine 51(11): 1665–1674.

112.

Rose

(1999a) Governing the Soul: The Shaping of the Private Self. London: Free Association.

113.

Rose

(1999b) Powers of Freedom – Reframing Political Thought. Cambridge: Cambridge University Press.

114.

Rose

Novas

(2005) Biological citizenship. In: Ong

Collier

(eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Oxford: Blackwell, 439–463.

115.

Rosenberg

(1997) Banishing risk, continuity and change in the moral management of disease. In: Brandt

Rozin

(eds) Morality and Health. New York: Routledge, 35–52.

116.

Roses

(2006) On the discovery of the genetic association of apolipoprotein E genotypes and common late-onset Alzheimer disease. Journal of Alzheimer’s Disease 9(3): 361–366.

117.

Roth

. (1966) Correlations between scores for dementia and counts of ‘senile plaques’ in cerebral grey matter of elderly patients. Nature 209: 110.

118.

Rothstein

(2003) Public Health and the Risk Factor: A History of an Uneven Medical Revolution. Rochester, NY: University of Rochester Press.

119.

Slooter

. (1997) Apolipoprotein E epsilon4 and the risk of dementia with stroke: A population-based investigation. Journal of the American Medical Association 277(10): 818–821.

120.

Snider

(2010) In home video games, it’s all about motion. USA Today 17 December, 1–2.

121.

Sparks

. (2010) Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment. Neurodegenerative Disease 7: 183–186.

122.

Sperling

Johnson

(2012) Dementia: New criteria but no new treatments. Journal of the American Medical Association 11(January): 4–5.

123.

Sperling

. (2011) Toward defining the preclinical stages of Alzheimer’s disease. Alzheimer’s & Dementia 7(3): 280–292.

124.

Tanzi

Parsson

(2000) Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Cambridge: Perseus.

125.

Timmermann

(2006) A matter of degree: The normalization of hypertension, circa 1940–1970. In: Ernst

(ed.) Histories of the Normal and the Abnormal. London: Routledge, 245–261.

126.

Timmermann

(2011) Appropriating risk factors: The reception of an American approach to chronic disease in the two German states, ca. 1950–1990. Social History of Medicine 25(1): 157–174.

127.

Vidal

(2009) Brainhood, anthropological figure of modernity. History of the Human Sciences 22: 5–36.

128.

Viner

(1999) Putting stress in life: Hans Selye and the making of stress theory. Social Studies of Science 29(3): 391–410.

129.

Wagener

(2004) DHEA-Das Altershormon. European Journal of Geriatrics 6(2): 67–81.

130.

Warner

(2005) Webmed health news. May. Available at: http://www.webmd.com/prostate-cancer/news/20050509/exercise-may-fight-prostate-cancer (accessed March 2011).

131.

WHO/EU (2006) WHO European Ministerial Draft Charter on Counteracting Obesity. Istanbul and Brussels: World Health Organization and European Union.

132.

Wilson

(2010) Risks seen in cholesterol drug use in healthy people. New York Times 30 March.

133.

Woolley

(2002) The Irritable Heart of Soldiers and the Origins of Anglo American Cardiology. Aldershot: Ashgate.

134.

Yamamura

. (1984) New mutants of apolipoprotein E associated with atherosclerotic diseases but not to Type III hyperlipoproteinemia. Journal of Clinical Investigation 74(4): 1229–1237.

135.

Ziguras

(2004) Self-care, Embodiment, Personal Autonomy and the Shaping of Health Consciousness. London: Routledge.